US OptionsDetailed Quotes
IPSC250117C2500
- 0.05
- 0.000.00%
15min DelayClose Jan 7 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume190 Open Interest2.50Strike Price0.00Turnover413.00%IV140.57%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1728Delta0.3599Gamma21.20Leverage Ratio-0.0093Theta0.0000Rho3.66Eff Leverage0.0004Vega
Century Therapeutics Stock Discussion
Sign in to post a comment
NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. NEVER be a blind follower.
LASTLY, If y...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. NEVER be a blind follower.
LASTLY, If y...
27
30
8
$Century Therapeutics (IPSC.US)$ 40 minutes to go buy once market opens or you you will be to late
$Century Therapeutics (IPSC.US)$ you cant lose on this theres more to gain than lose 🐮 what are yall waiting for? #Buynow
$Century Therapeutics (IPSC.US)$
Clear Street Launches Healthcare & Biotechnology Equity Research
Tuesday, 17th December at 2:00 pm
Comprehensive Biotechnology sector market analysis and investment insights complement recently launched Disruptive Technology and Energy Transition franchises
Clear Street, ("Clear Street", "the Company") a cloud-native financial technology firm on a mission to modernize the brokerage ecosystem, today announced the expansion of its recently launched equity resear...
Clear Street Launches Healthcare & Biotechnology Equity Research
Tuesday, 17th December at 2:00 pm
Comprehensive Biotechnology sector market analysis and investment insights complement recently launched Disruptive Technology and Energy Transition franchises
Clear Street, ("Clear Street", "the Company") a cloud-native financial technology firm on a mission to modernize the brokerage ecosystem, today announced the expansion of its recently launched equity resear...
Keep an eye on these M&As: 👀
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt (ADTX.US)$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics (KTRA.US)$
$Johnson & Johnson (JNJ.US)$ to acquire $ShockWave Medical (SWAV.US)$
$Vertex Pharmaceuticals (VRTX.US)$ to acquire $Alpine Immune (ALPN.US)$
$Century Therapeutics (IPSC.US)$ to acquire Clade Tx
$Eliem Therapeutics (ELYM.US)$ to acquire Tenet Med.
$Incyte (INCY.US)$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals (DCPH.US)$
...
Onconova Tx merger w/ Trawsfynydd Tx
$Aditxt (ADTX.US)$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics (KTRA.US)$
$Johnson & Johnson (JNJ.US)$ to acquire $ShockWave Medical (SWAV.US)$
$Vertex Pharmaceuticals (VRTX.US)$ to acquire $Alpine Immune (ALPN.US)$
$Century Therapeutics (IPSC.US)$ to acquire Clade Tx
$Eliem Therapeutics (ELYM.US)$ to acquire Tenet Med.
$Incyte (INCY.US)$ to acquire Escient Pharm.
ONO Pharm to acquire $Deciphera Pharmaceuticals (DCPH.US)$
...
7
$Century Therapeutics (IPSC.US)$ Century Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Casdin Capital, LLC(6.08%),Eli Casdin(6.08%)![]()
1
2
$Century Therapeutics (IPSC.US)$ Century Therapeutics Strengthens Position In Autoimmune Disease With Strategic Pipeline Expansion Supported By $60 Million Private Placement And Acquisition Of Clade Therapeutics >IPSC
Dow Jones· 3 mins ago
Dow Jones· 3 mins ago
1
$Century Therapeutics (IPSC.US)$ Century Therapeutics Presents New Preclinical Data Highlighting IPSC-Derived Cell Therapy Platform Technology At The 2024 AACR Annual Meeting
Benzinga· 4 mins ago
Benzinga· 4 mins ago
Insider selling at Century Therapeutics is worrisome despite low volume. Absence of recent insider buying is a negative sign. Yet, insider ownership level shows some alignment between management and smaller shareholders.
$Century Therapeutics (IPSC.US)$ correct time to enter in ?
No comment yet
105711797 : jaguar, whats your take on cnsp now, what price would be a target now?
Jaguar8 OP 105711797 : It will just be a PM play for me.
Diaper Fund 4 MyGirl : The market will not close on Wednesday.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Jaguar8 OP Diaper Fund 4 MyGirl : Thursday it will closed
Adam_Flannery : NFA but hella bullish on SRM looks really fishy tho
View more comments...